Horizon Therapeutics Public Limited Company Stock Price and Value Analysis

Should you buy Horizon Therapeutics Public Limited Company stock? (NasdaqGS:HZNP). Let's see how it does in our automated value investing analysis system.

HZNP Free Cash Flow Trend

Free Cash Flow trendline for HZNP
Free Cash Flow trendline for Horizon Therapeutics Public Limited Company

Hmm, we can't give any reliable projection for Horizon Therapeutics Public Limited Company's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

AdvantagesDisadvantagesNeutral
None.
  • This company is not making money.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the HZNP Numbers

HZNP Price
(Horizon Therapeutics Public Limited Company stock price per share)
$27.00
PE Ratio versus Sector 279% higher than other Healthcare stocks
PE Ratio versus Industry 485% higher than other Drug Manufacturers - Specialty & Generic stocks
Cash Yield 6.60%
Free Cash Flow Jitter 87%

Is Horizon Therapeutics Public Limited Company Stock on Sale?

Based on our analysis, we believe that you should not buy Horizon Therapeutics Public Limited Company right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy HZNP Stock?

Does Horizon Therapeutics Public Limited Company have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.